Structure-activity relationships for a class of inhibitors of purine nucleoside phosphorylase

被引:36
作者
Farutin, V
Masterson, L
Andricopulo, AD
Cheng, JM
Riley, B
Hakimi, R
Frazer, JW
Cordes, EH
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
关键词
D O I
10.1021/jm990037y
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Values of inhibition constants, K-i, for a family of structurally related, competitive inhibitors of calf spleen purine nucleoside phosphorylase (PNP) have been determined employing both inosine as substrate and a manual assay and 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) as substrate and a robot-based enzyme kinetics facility. Several of the values determined robotically were confirmed employing the same substrate and a manual assay. Surprisingly, for many of the inhibitors examined, values of K-i determined with MESG as substrate are smaller than those obtained employing inosine as substrate by a factor that varies from less than 2 to 10. Values of concentrations required for 50% inhibition of PNP, IC50, have also been determined for the same family of inhibitors employing inosine as substrate. Values of IC50ino and those for K-i(ino) and K-i(mesg) for subsets of the inhibitors have been employed as training sets to create quantitative structure-activity relationships (QSAR) which have substantial power to predict values of IC50 and K-i for inhibitors outside the training set. These QSAR models should be useful in guiding future medicinal chemistry efforts designed to discover inhibitors of PNP having increased potency.
引用
收藏
页码:2422 / 2431
页数:10
相关论文
共 18 条
  • [1] BRENEMAN C, 1996, MOL ELECTROSTATIC PO
  • [2] Breneman CM, 1997, J COMPUT CHEM, V18, P182, DOI 10.1002/(SICI)1096-987X(19970130)18:2<182::AID-JCC4>3.0.CO
  • [3] 2-R
  • [4] ELECTRON-DENSITY MODELING OF LARGE SYSTEMS USING THE TRANSFERABLE ATOM EQUIVALENT METHOD
    BRENEMAN, CM
    THOMPSON, TR
    RHEM, M
    DUNG, M
    [J]. COMPUTERS & CHEMISTRY, 1995, 19 (03): : 161 - &
  • [5] CHENG J, 1999, IN PRESS BIOORG CHM, V42
  • [6] STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE .3. 9-ARYLMETHYL DERIVATIVES OF 9-DEAZAGUANINE SUBSTITUTED ON THE METHYLENE GROUP
    ERION, MD
    NIWAS, S
    ROSE, JD
    ANANTHAN, S
    ALLEN, M
    SECRIST, JA
    BABU, YS
    BUGG, CE
    GUIDA, WC
    EALICK, SE
    MONTGOMERY, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (24) : 3771 - 3783
  • [7] STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE .4. A STUDY OF PHOSPHATE MIMICS
    GUIDA, WC
    ELLIOTT, RD
    THOMAS, HJ
    SECRIST, JA
    BABU, YS
    BUGG, CE
    ERION, MD
    EALICK, SE
    MONTGOMERY, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) : 1109 - 1114
  • [8] Comparative QSAR: Toward a deeper understanding of chemicobiological interactions
    Hansch, C
    Hoekman, D
    Gao, H
    [J]. CHEMICAL REVIEWS, 1996, 96 (03) : 1045 - 1075
  • [9] KARLESON M, 1996, CHEM REV, V96, P1027
  • [10] Leo A, 1995, EXPLORING QSAR FUNDA